These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9596383)
1. Hepatitis C virus transmission dynamics in injection drug users. Hagan H Subst Use Misuse; 1998 Apr; 33(5):1197-212. PubMed ID: 9596383 [TBL] [Abstract][Full Text] [Related]
2. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts. Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028 [TBL] [Abstract][Full Text] [Related]
3. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users. Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population. Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508 [TBL] [Abstract][Full Text] [Related]
7. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Weissenbacher M; Rossi D; Radulich G; Sosa-Estáni S; Vila M; Vivas E; Avila MM; Cuchi P; Rey J; Peralta LM Clin Infect Dis; 2003 Dec; 37 Suppl 5():S348-52. PubMed ID: 14648445 [TBL] [Abstract][Full Text] [Related]
8. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Murrill CS; Weeks H; Castrucci BC; Weinstock HS; Bell BP; Spruill C; Gwinn M Am J Public Health; 2002 Mar; 92(3):385-7. PubMed ID: 11867316 [TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of viral infections among intravenous drug users in northern California. Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362 [TBL] [Abstract][Full Text] [Related]
10. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050 [TBL] [Abstract][Full Text] [Related]
11. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Devi KhS; Brajachand N; Singh HL; Singh YM J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea. Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858 [TBL] [Abstract][Full Text] [Related]
13. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
16. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users. Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and C infection among drug abusers in Nepal. Shrestha SM; Shrestha DM; Gafney TE; Maharjan KG; Tsuda F; Okamoto H Trop Gastroenterol; 1996; 17(4):212-3. PubMed ID: 9094859 [TBL] [Abstract][Full Text] [Related]
18. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Shapatava E; Nelson KE; Tsertsvadze T; del Rio C Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237 [TBL] [Abstract][Full Text] [Related]
20. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]